Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 14 August 2020 - 09 September 2020
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- Test conducted in accordance with OECD Test Guideline and in accordance with GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 020
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity: Fixed Dose Procedure)
- Version / remarks:
- 09 October 2017
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
- Limit test:
- yes
Test material
- Test material form:
- liquid
- Details on test material:
- Storage conditions: At room temperature protected from light
Physical description: Light orange liquid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- Crl: WI(Han)
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Deutschland, Sulzfeld, Germany
- Females nulliparous and non-pregnant: yes
- Rationale for use of males (if applicable): N/A
- Age at study initiation: Single young adult animal (approx. 10 weeks old)
- Weight at study initiation: 181 g
- Fasting period before study: Not specified
- Housing: On arrival, the animal was group housed (up to 5 animals of the same sex together) in polycarbonate cages (Makrolon MIV type; height 18 cm.) and following assignment to the study, the animal was individually housed in polycarbonate cages (Makrolon MIII type; height 18 cm.) containing sterilized wooden fibers as bedding material (Lignocel S 8-15, JRS - J.Rettenmaier & Söhne GmbH + CO. KG, Rosenberg, Germany) equipped with water bottles. The room in which the animal was kept was documented in the study records. The cage was clearly labeled.
- Historical data:
- Diet: Pelleted rodent diet (SM R/M-Z from SSNIFF® Spezialdiäten GmbH, Soest, Germany) was provided ad libitum throughout the study, except during designated procedures.
The feed was analyzed by the supplier for nutritional components and environmental contaminants. Results of the analysis were provided by the supplier and are on file at the Test Facility. It is considered that there were no known contaminants in the feed that would interfere with the objectives of the study.
- Water (e.g. ad libitum): Municipal tap-water was freely available to each animal via water bottles. Periodic analysis of the water was performed, and results of these analyses are on file at the Test Facility. It is considered that there were no known contaminants in the water that would interfere with the objectives of the study.
- Acclimation period: The animal was allowed to acclimate to the Test Facility toxicology accommodation for at least 5 days before the commencement of dosing.
- Microbiological status when known: Not reported
- Method of randomisation in assigning animals to test and control groups:
Animals were assigned to the study at the discretion of the coordinating biotechnician, with all animals within ± 20% of the sex mean body weights. Animals in poor health or at extremes of body weight range were not assigned to the study.
Before the initiation of dosing, a health inspection was performed, and any assigned animal considered unsuitable for use in the study were replaced by alternate animals obtained from the same shipment and maintained under the same environmental conditions.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): Actual daily mean temperature during study period: 21-22°C
- Humidity (%): Actual daily mean relative humidity during study period: 48 -70%
- Air changes (per hr): => 10/h with 100% fresh air (no air recirculation)
- Photoperiod (hrs dark / hrs light): 12 hour light/12 hour dark cycle
- Animal enrichment: For psychological/environmental enrichment, the animal was provided with paper (Enviro-dri, Wm. Lillico & Son (Wonham Mill Ltd), Surrey, United Kingdom)
IN-LIFE DATES: From: 14 August 2020 To: 09 September 2020
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: The test item was applied to approx. 18 cm² .
- % coverage: Approx. 10 %
- Type of wrap if used: The test item was held in contact with the skin with a dressing, consisting of a surgical gauze patch (Surgy 1D), successively covered with Coban elastic bandage. A piece of Micropore tape was additionally used for fixation of the bandages.
REMOVAL OF TEST SUBSTANCE
- Washing (if done):
- Time after start of exposure:
TEST MATERIAL
- Amount(s) applied (volume or weight with unit):
- Concentration (if solution):
- Constant volume or concentration used: yes/no
- For solids, paste formed: yes/no
VEHICLE
- Amount(s) applied (volume or weight with unit):
- Concentration (if solution):
- Lot/batch no. (if required):
- Purity: - Duration of exposure:
- Application period: 24 h, after which the dressing was removed, and the skin cleaned of residual test item using water.
- Doses:
- 2000 mg/kg
The dose volume for the animal was based on the body weight measurement prior to dosing. Dose volume (mL/kg body weight) was calculated as follows: Dose level (g/kg) / spec.gravity or density (g/mL) * purity correction factor.
Animal welfare reasons prevented the initiation of the main study due to severe skin effects, therefore no addiitonal doses were applied. - No. of animals per sex per dose:
- A single female was dosed at the single 2000 mg/kg bw dose.
- Control animals:
- other: Adjacent areas of untreated skin of the animal served as a control
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Throughout the study, the animal was observed for general health/mortality and moribundity twice daily, in the morning and at the end of the working day. Post-dose observations were performed at periodic intervals on the day of dosing (at least three times) and once daily thereafter. The animal was examined for reaction to dosing. The onset, intensity and duration of these signs was recorded (if appropriate), particular attention being paid to the animal during and for the first hour after dosing.
The animal was weighed individually on Day 1 (pre-dose), 8 and 15.
- Necropsy of survivors performed: yes
- Clinical signs including body weight: yes
- Other examinations performed: clinical signs, macroscopic findings - Statistics:
- Not applicable, only a single dose was applied to a single animal during the test
Results and discussion
- Preliminary study:
- The results from the single animal dosed at 2000 mg/kg are as follows:
No mortality occurred.
Systemic signs of toxicity consisted of hunched posture on Days 3-5.
Local toxicity consisted of very slight to well-defined erythema between 24- and 72-hours post-dosing. Red discoloration was seen between Days 2 and 7, which resulted in flaking, signs of necrosis and/or scabs on the lumbar skin / right flank between Days 2 and 15.
The body weight gain shown by the animal during the observation period was within the range expected for rats used in this type of study.
No abnormalities were found at macroscopic post-mortem examination of the animal.
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- no indication of skin irritation up to the relevant limit dose level
- Remarks:
- Minor transient systemic toxicity (hunched posture) was observed and mortality is not to be expected if additional animals were dosed.
- Mortality:
- None
- Clinical signs:
- Minor transient systemic toxicity (hunched posture) was observed on Days 3-5.
Local toxicity consisted of very slight to well-defined erythema between 24- and 72-hours post-dosing. Red discoloration was seen between Days 2 and 7, which resulted in flaking, signs of necrosis and/or scabs on the lumbar skin / right flank between Days 2 and 15. - Body weight:
- The body weight gain shown by the animal during the observation period was within the range expected for rats used in this type of study.
- Gross pathology:
- No abnormalities were found at macroscopic post-mortem examination of the animal.
- Other findings:
- N/A
Any other information on results incl. tables
Table 1. Individual Mortality - Female Day(s): - Relative to Start Date
2000 mg/kg Group 1 |
|
|
|
Day of Death |
Removal Date |
Path Removal Reason |
|
1 |
15 |
09-Sep-2020 |
Terminal euthanasia |
Table 2. Individual Clinical Observations
Group 1 Sex: Female 2000 mg/kg |
||||||||||||||||||
|
Observation Type: All Types |
Day(s) Relative to Start Date |
||||||||||||||||
1 0h |
1 2h |
1 4h |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
||
1 |
Hunched Posture |
. |
. |
. |
. |
X |
X |
X |
. |
. |
. |
. |
. |
. |
. |
. |
. |
. |
|
Skin, Flaking, Lumbar, Grade 1 |
. |
. |
. |
. |
. |
X |
X |
X |
. |
. |
. |
. |
. |
X |
. |
X |
X |
|
Skin, Flaking, Lumbar, Grade 2 |
. |
. |
. |
. |
. |
. |
. |
. |
X |
X |
X |
X |
. |
. |
X |
. |
. |
|
Skin, Flaking, Lumbar, Moderate |
. |
. |
. |
. |
. |
. |
. |
. |
. |
. |
. |
. |
X |
. |
. |
. |
. |
|
Skin, Discolored, Lumbar, Red |
. |
. |
. |
X |
X |
X |
X |
X |
X |
. |
. |
. |
. |
. |
. |
. |
. |
|
Skin, Scab, Lumbar |
. |
. |
. |
. |
X |
X |
X |
X |
X |
X |
X |
X |
X |
X |
X |
X |
X |
X = present
Table 3. Individual Body Weights - Female
2000 mg/kg Group 1 |
Day(s) Relative to Start Date |
||
1 |
8 |
15 |
|
1 |
181 |
193 |
203 |
Mean |
181.0 |
193.0 |
203.0 |
SD |
- |
- |
- |
N |
1 |
1 |
1 |
Table 4. Irritation Observations
Group 1 Sex: Female 2000 mg/kg |
||||
|
Observation Type: All Types |
Day(s) Relative to Start Date |
||
3 24H |
4 48H |
5 72H |
||
1 |
Erythema, Lumbar, Grade 1 |
X |
X |
. |
|
Erythema, Lumbar, Grade 2 |
. |
. |
X |
|
Other (see comment), Right Subcapsulara |
X |
X |
X |
a Scab on right flank showing necrosis.
X = Present
Individual Macroscopic Pathology:
Animal: 1, Group: 1, Sex: Female, Dose: 2000 mg/kg, Removal Reason: Terminal Euthanasia
Study Day (Week) of Death: 15 (3)
Gross Status: Complete
Gross Pathology Observations [Correlation]:
No observations found
Gross Pathology - The following Tissues were Not Examined:
None
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The dermal LD50 value of the test item in Wistar Han rats was established to be > 2000 mg/kg body weight.
- Executive summary:
A test was performed in accordance with OECD 402 (2017), in order to determine the potential toxicity of the test item, when given by a single dermal dose.
Initially, the test item was administered to a single female Wistar Han rat by a single dermal application at 2000 mg/kg body weight for 24 hours in a range finder study. The animal was subjected to daily observations and weekly determination of body weight. Macroscopic examination was performed after terminal sacrifice (Day 15).
No mortality occurred. Furthermore, the body weight gain shown by the animal during the observation period was within the range expected for rats used in this type of study and no abnormalities were found at macroscopic post-mortem examination. Hunched posture was noted between Days 3 and 5. Local toxicity consisted of very slight to well-defined erythema between 24- and 72-hours post-dosing. Red discoloration was seen between Days 2 and 7, which resulted in flaking, signs of necrosis and/or scabs on the lumbar skin / right flank between Days 2 and 15. Based on the severity of these effects, it was considered that the other two animals assigned to the main study could not be dosed for animal welfare reasons.
Based on the results, it can be stated that the dermal LD50 value exceeds 2000 mg/kg, because only minor transient systemic toxicity (hunched posture) was observed and mortality is not to be expected if additional animals were dosed.
Based on these results, the test item would not be classified in accordance with Regulation (EC) No 1272/2008 on Classification, Labelling and Packaging of Substances and Mixtures.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Aunque la ECHA ofrece una gran cantidad de material en su idioma, una parte de esta página está solo disponible en inglés. Más información sobre la política de multilingüismo de la ECHA.
Bienvenido a la página web de la ECHA. Este sitio no es plenamente compatible con Explorer 7 (y versiones anteriores). Por favor, actualice su Internet Explorer a una versión más reciente.
Esta web utiliza cookies para mejorar su experiencia de navegación en nuestros sitios web.
Más información sobre el uso de cookies.